Biomagnetics goes East for expansion:
This article was originally published in Clinica
Executive Summary
Biomagnetics Diagnostics is to set up a subsidiary in China in a bid to capitalise on the growth opportunities in that market as well as in the rest of Asia. The business unit will be a publicly-listed company trading on either the Shenzhen or Hong Kong stock exchange, said the Orangevale, California-based company. The move is part of the firm's global marketing strategy for its high thoroughput screening-magnetic testing platform (HTS-MTP). The technology is designed to provide both qualitative and quantitative detection of any pathogen, including HIV, in minutes at a low cost, according to Biomagnetics.